DNA-4 HIV vaccine (The Biomedical Center)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDNA-4 HIV vaccine (The Biomedical Center)

Drug Alias NameDNK-4

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionGlycosaminoglycan modulatorsEnvelope glycoprotein gp160 modulatorsHuman immunodeficiency virus type 1 REV modulators

TargetsEnvelope glycoprotein gp160Human immunodeficiency virus type 1 REVGlycosaminoglycan

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe Biomedical Center(Saint Petersburg, Russia)

China Registration ClassN/A

Develop Information

Active CompaniesThe Biomedical Center(Saint Petersburg, Russia)

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A